Fitc-LEED-FMK integrates a LEED recognition motif with FMK reactivity and a FITC fluorophore for detection. The construct allows visualization of protease binding and irreversible modification. Researchers apply it in assays monitoring catalytic activity and substrate preference. Its fluorescence improves sensitivity in real-time kinetic analysis.
CAT No: HB00043
Fitc-LEED-FMK is a synthetic peptide inhibitor that is covalently labeled with fluorescein isothiocyanate (FITC) for direct fluorescence detection. As a tetrapeptide analog incorporating the FMK (fluoromethyl ketone) reactive group, it is specifically engineered to irreversibly inhibit a subset of cysteine proteases, particularly caspase-4 and related enzymes. The inclusion of the FITC moiety enables real-time visualization and quantification of enzyme-inhibitor interactions in cellular and biochemical systems. Its unique structure makes it a valuable molecular probe for dissecting the functional roles of inflammatory caspases and studying protease-mediated signaling pathways in apoptosis and immune responses.
Enzyme Inhibition Studies: In experimental systems focused on the regulation of cysteine proteases, Fitc-LEED-FMK serves as a potent, irreversible inhibitor. Researchers utilize it to selectively block caspase-4 activity, thereby dissecting the enzyme's contribution to cellular processes such as pyroptosis and inflammatory signaling. The FMK group covalently binds to the active site cysteine, rendering the protease inactive and allowing for precise functional studies in both cell-free extracts and intact cells.
Fluorescence-Based Detection: The FITC label on this inhibitor enables direct visualization of protease engagement in live or fixed cells. By tracking the fluorescent signal, investigators can monitor the spatial and temporal dynamics of inhibitor uptake, distribution, and target engagement. This approach provides a powerful means to quantify protease activity in situ, facilitating high-content imaging and flow cytometry applications in cell biology and immunology research.
Protease Profiling and Target Validation: Fitc-LEED-FMK is widely employed in protease profiling assays to distinguish caspase-4 activity from that of related enzymes. Its selectivity and irreversible mode of action make it suitable for target validation experiments, where confirming the identity and role of specific proteases is critical. The fluorescent readout further streamlines multiplexed assays and supports the development of novel screening platforms for protease modulators.
Cell Death Pathway Analysis: In studies investigating the molecular mechanisms of programmed cell death, this peptide inhibitor is instrumental for delineating the involvement of caspase-4 in apoptosis and inflammatory cell death pathways. By selectively suppressing caspase-4 function, scientists can unravel the downstream signaling events and cross-talk with other caspases or proteolytic systems, providing mechanistic insights into immune regulation and cellular stress responses.
Assay Development and Optimization: The dual functionality of Fitc-LEED-FMK as both an inhibitor and a fluorescent probe makes it a valuable tool for developing and optimizing biochemical and cell-based assays. Its use accelerates the screening of novel protease inhibitors, supports the validation of assay specificity, and enhances the robustness of high-throughput formats. The reagent's compatibility with various detection platforms ensures its utility across a broad spectrum of experimental workflows in academic and industrial research settings.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More